Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Journal of Leukocyte Biology
|
February 5, 2010
Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization
Jeremy P McAleer, Bei Liu, Zihai Li, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
August 27, 2015
The Potentiation of IFN-γ and Induction of Cytotoxic Proteins by Pegylated IL-10 in Human CD8 T Cells
Ivan Ho Chan, Victoria Wu, Melissa Bilardello, et al.
Cancer Research
|
May 15, 2012
IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs
Jan Emmerich, John B Mumm, Ivan H Chan, et al.
Antibodies (Basel, Switzerland)
|
September 22, 2025
Structure-Guided Stapling of Dimeric Conformations and Linker Engineering Enhance Thermostability and Fine-Tune Activity of Bispecific VHH Cytokine Agonists
Raphael Trenker, Deepti Rokkam, Andrew Morin, et al.
Cancer Research
|
February 3, 2006
Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition
Markus D Lacher, Maarit I Tiirikainen, Elise F Saunier, et al.
Nature
|
May 12, 2006
IL-23 promotes tumour incidence and growth
John L Langowski, Xueqing Zhang, Lingling Wu, et al.
Plos One
|
June 15, 2016
PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia
Ivan H Chan, Dennis Van Hoof, Marina Abramova, et al.
Case Reports in Oncology
|
May 18, 2019
Interleukin 10-Mediated Response and Correlated Anemia in a Patient with Advanced Non-Small Cell Lung Carcinoma
Khalil Choucair, Jesse D Kelso, Joseph R Duff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 21, 2010
IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis
Michele W L Teng, Daniel M Andrews, Nicole McLaughlin, et al.
Science Translational Medicine
|
December 22, 2021
An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma
Paul-Joseph Aspuria, Sandro Vivona, Michele Bauer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Journal of Leukocyte Biology
|
February 5, 2010
Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization
Jeremy P McAleer, Bei Liu, Zihai Li, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
August 27, 2015
The Potentiation of IFN-γ and Induction of Cytotoxic Proteins by Pegylated IL-10 in Human CD8 T Cells
Ivan Ho Chan, Victoria Wu, Melissa Bilardello, et al.
Cancer Research
|
May 15, 2012
IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs
Jan Emmerich, John B Mumm, Ivan H Chan, et al.
Antibodies (Basel, Switzerland)
|
September 22, 2025
Structure-Guided Stapling of Dimeric Conformations and Linker Engineering Enhance Thermostability and Fine-Tune Activity of Bispecific VHH Cytokine Agonists
Raphael Trenker, Deepti Rokkam, Andrew Morin, et al.
Cancer Research
|
February 3, 2006
Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition
Markus D Lacher, Maarit I Tiirikainen, Elise F Saunier, et al.
Nature
|
May 12, 2006
IL-23 promotes tumour incidence and growth
John L Langowski, Xueqing Zhang, Lingling Wu, et al.
Plos One
|
June 15, 2016
PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia
Ivan H Chan, Dennis Van Hoof, Marina Abramova, et al.
Case Reports in Oncology
|
May 18, 2019
Interleukin 10-Mediated Response and Correlated Anemia in a Patient with Advanced Non-Small Cell Lung Carcinoma
Khalil Choucair, Jesse D Kelso, Joseph R Duff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 21, 2010
IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis
Michele W L Teng, Daniel M Andrews, Nicole McLaughlin, et al.
Science Translational Medicine
|
December 22, 2021
An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma
Paul-Joseph Aspuria, Sandro Vivona, Michele Bauer, et al.
Page
of 3